Loading ......
M. Tuberculosis Antigens from Creative Diagnostics serve as dependable tools for Mycobacterium tuberculosis detection and identification through their high performance capabilities. The antigens undergo advanced immunoassay development and strict quality control procedures which result in superior sensitivity and specific detection with reliable outcomes. The antigens receive full validation testing to ensure dependable operation and extended shelf life and exact pathogen identification capabilities. The M. Tuberculosis Antigens serve multiple applications in tuberculosis diagnostics and immunology research and disease surveillance and assay development to help identify pathogens accurately and detect diseases early and support worldwide TB control efforts.

M. Tuberculosis Antigens from Creative Diagnostics provide superior performance for immunoassay applications. The antigens undergo rigorous quality control assessments to achieve high sensitivity and specific detection along with reliable reproducibility and extended stability for diagnostic and research applications. The antigens function in various tuberculosis-related applications including disease detection and vaccine creation and immunological studies and disease monitoring and assay optimization. Our product advantages:
Our organization supports tuberculosis diagnostics and immunology research through the provision of complete M. Tuberculosis Antigen sets. The antigens undergo production through advanced immunoassay technologies and screening validation systems which enable accurate Mycobacterium tuberculosis detection. The antigens receive thorough quality control testing and complete characterization to verify their stability and reproducibility and production lot consistency. The validation process evaluates antigen specificity and accuracy and long-term stability to deliver dependable results for laboratory and clinical research needs. M. Tuberculosis Antigens serve multiple purposes in TB diagnostics and vaccine development and T-cell immunology research and disease surveillance and assay creation. The antigens fulfill strict quality requirements and receive comprehensive expert handling to produce dependable high-quality results which enable important scientific discoveries.
| Cat_No | Product Name | Expression system | Application | |
| DAGA-169 | Recombinant M. Tuberculosis 15.3 kDa | E. coli | ELISA, LFIA, WB | Inquiry |
| DAG-T2449 | Recombinant M. Tuberculosis 16 kDa | E. coli | EIA, ELISA | Inquiry |
| DAG-T2447 | Recombinant M. Tuberculosis 38 kDa | E. coli | EIA, ELISA | Inquiry |
| DAGA-191 | Recombinant M. Tuberculosis 48 kDa | E. coli | ELISA | Inquiry |
| DAGA-190 | Recombinant M. Tuberculosis 63 kDa | E. coli | ELISA, WB | Inquiry |
| DAGA-181 | Recombinant M. Tuberculosis 85-A | E. coli | WB, ELISA | Inquiry |
| DAGA-192 | Recombinant M. Tuberculosis 85-A | Hi-5 cells | SDS-PAGE | Inquiry |
| DAGA-189 | Recombinant M. Tuberculosis 85-A | Baculovirus | SDS-PAGE | Inquiry |
| DAGA-185 | Recombinant M. Tuberculosis 85-B | E. coli | WB, ELISA | Inquiry |
| DAGA-175 | Recombinant M. Tuberculosis 85-C | E. coli | WB, ELISA | Inquiry |
| DAGA-170 | Recombinant M. Tuberculosis CFP-10 | E. coli | ELISA | Inquiry |
| DAGA-193 | Recombinant M. Tuberculosis CFP10/ ESAT6 Chimera Protein | E. coli | EIA, WB | Inquiry |
| DAGA-187 | Recombinant M. Tuberculosis ESAT-6 | E. coli | WB, ELISA | Inquiry |
| DAGA-168 | Native M. Tuberculosis LAM Antigen | Native | ELISA | Inquiry |
Background:
A university research team worked to create an advanced T-cell based diagnostic tool for detecting latent tuberculosis infection (LTBI). The researchers needed well-defined M. Tuberculosis antigens because current tests generated numerous false positive results while showing low specificity.
Materials & Methods:
Results:
Conclusion:
The research established that precise and reliable immunodiagnostic assays become possible through the use of high-quality M. Tuberculosis antigens which have been thoroughly characterized. The application of these antigens enables better TB detection at early stages and supports vaccine development and host immune system research.
They're proteins or molecules from Mycobacterium tuberculosis that our immune system recognizes. Researchers and clinicians use them to detect TB, study immune responses, and develop vaccines.
Absolutely! They work in ELISA, IGRA, T-cell assays, and other immunological tests, making them versatile for diagnostics and research.
Not quite. Some are recombinant (lab-made) for consistency, while others come from natural TB bacteria. Each has unique properties depending on your research or diagnostic needs.
Very reliable. They go through strict quality control, full characterization, and batch validation to ensure consistent, reproducible, and stable performance.
Yes! Scientists use them to study immune responses, identify protective targets, and test new vaccine candidates against TB.
Loading ......